MedPath

Effect of Radiofrequency of Suprascapular Nerve in Shoulder Reverse Arthroplasty

Not Applicable
Conditions
Rotator Cuff Tear Arthropathy
Post Operative Pain
Registration Number
NCT05785572
Lead Sponsor
Hospital Universitario Virgen Macarena
Brief Summary

The purpuse of this study is to asses if the pulsed radiofrecuency of the supraescapular nerve and accesory nerve have the same or superior efectivity controlling the acute postoperative pain than interscalenic braquial plexus block

Detailed Description

This is a randomized, double-blind trial that compares the effect in postoperative pain of pulsed radiofrecuency of the supraescapular nerve carried out at least two to four weeks before reverse total shoulder arthroplasty surgery with interscalenic braquial plexus block done at the moment of the surgery. All the patients received conventional general anaesthesia and multimodal postoperative analgesia with additional patient-controlled rescue analgesics were prescribed

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Visual analogical scaleperiodical measurements of pain, inmediate preoperative pain up to three months postoperative

Postoperative acute pain measurement. From 0 to 10, Zero means no pain and ten would be the worse pain that the paitient could feel.

Secondary Outcome Measures
NameTimeMethod
Visual analogical scale3 months postop. until 1 year postop

chronic pain after surgery. From 0 to 10, Zero means no pain and ten would be the worse pain that the paitient could feel.

Trial Locations

Locations (1)

Hospital Universitario Virgen Macarena

🇪🇸

Sevilla, Spain

Hospital Universitario Virgen Macarena
🇪🇸Sevilla, Spain
Maria Carmen Gonzalez Lopez
Contact
0034 675175531
mcglez89@gmail.com
Jesus Garcia Hernandez
Contact
0034 690739292
jesusgciahdez@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.